| Antimicrobial agent | MIC (μg/mL) | Susceptibility* |
|---|---|---|
| Chloramphenicol | 2.00 | – |
| Erythromycin | 0.50 | I |
| Clindamycin | 0.50 | I |
| Daptomycin | 1.00 | – |
| Oxacillin | > 4.00 | – |
| Gentamicin | 2.00 | – |
| Ampicillin | 0.12 | – |
| Cefoxitin | < 6.00 | – |
| Linezolid | 1.00 | – |
| Penicillin | 0.06 | S |
| Rifampin | 0.50 | – |
| Vancomycin | 0.50 | S |
| Trimethoprim/sulfamethoxazole | 0.50 | – |
| Levofloxacin | 4.00 | I |
| Ciprofloxacin | > 2.00 | – |
| Quinupristin/dalfopristin | < 0.50 | – |
| Tigecycline | < 0.03 | – |
| Nitrofurantoin | < 32.00 | – |
| Tetracycline | 16.00 | – |
| Moxifloxacin | < 2.00 | – |
*The drug susceptibility of Gemella sanguinis in the present case was determined using the Sensititre gram positive plate, GPALL1F panel, and the 2016 Clinical and Laboratory Standards Institute (M45-ED3) criteria for Gemella species. Abbreviations: MIC, minimum inhibitory concentration; S, susceptible; I, intermediate.